ZAS Corporation recently held a strategic business overview meeting with its esteemed global partner, Celltrion from Korea. The session focused on sharing insights, aligning future plans, and exploring new opportunities for growth. Both teams discussed the current business landscape and reaffirmed their commitment to delivering innovative solutions together. This collaboration continues to reinforce ZAS Corporation’s dedication to excellence and global partnerships.
More Releases
ZAS Corporation Participates in Anesthesia Day 2025, Strengthening Commitment to Patient Care
https://www.facebook.com/share/v/1a9fjSn8TH
ZAS Corporation was privileged to participate in the Anesthesia...
ZAS Corporation Launches DECA® Surgical Glove Series, A New Era in Surgical Excellence
ZAS Corporation proudly announces the official launch of its DECA® series of sterile surgical gloves,...
ZAS Corporation Strengthens Partnership with Celltrion Korea
ZAS Corporation recently held a strategic business overview meeting with its esteemed global partner,...
ZAS Industries Launches Advanced Wound Care Products from Pharmaplast.
ZAS Industries proudly announces the launch of a new range of premium wound care products from Pharmaplast,...
ZAS Corporation & BIRDEM General Hospital Introduce Advanced Biosimilar Therapies in Rheumatology Care
ZAS Corporation is proud to collaborate with the Rheumatology Department of BIRDEM General Hospital to...
ZAS Corporation Highlights Urovaxom® at OGSB International Scientific Conference 2025
ZAS Corporation Ltd. was honored to take part in the 33rd International Scientific Conference & 51st...
ZAS Corporation Hosts CME on Advancing Psoriasis Care with Adalimumab
ZAS Corporation’s Dermatology Division recently organized a Continuing Medical Education (CME) program...
ZAS Corporation Empowers ICU Nurses with Noradrenaline Best Practices Training
ZAS Corporation recently organized a series of training sessions across multiple hospitals, engaging...
ZAS Onco & MOSB Host Scientific Seminar on Recent Advances in Bevacizumab Therapy
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh...
ZAS Corporation Joins Aqvida GmbH in Celebrating 20 Years of Oncology Excellence in Germany
Hamburg & Dassow, Germany | 14–17 May 2025ZAS Corporation proudly participated in the 20th anniversary...